Philips Korea and HoneyNaps Partner on Sleep and Cardiovascular Health
Philips Korea and HoneyNaps have signed a strategic Memorandum of Understanding (MOU) to explore new healthcare opportunities linked to sleep disorders and cardiovascular disease.

Philips Korea and HoneyNaps have signed a strategic Memorandum of Understanding (MOU) to explore new healthcare opportunities stemming from the connection between sleep disorders and cardiovascular disease. The collaboration aims to integrate sleep data with cardiovascular risk factors and pursue academic initiatives.
The partnership will focus on leveraging insights from sleep monitoring technology and cardiovascular health data to develop preventative and diagnostic tools. The goal is to better understand and address the complex relationship between sleep quality and heart health.
By combining Philips' expertise in health technology with HoneyNaps' specialization in sleep analysis, the collaboration seeks to create novel healthcare solutions. This initiative is expected to contribute to improved patient outcomes and a more holistic approach to managing chronic conditions.
The MOU was signed in Seoul, South Korea. Both companies anticipate that this collaboration will pave the way for future research and development projects, ultimately enhancing the understanding and management of health conditions influenced by sleep patterns.